Tapewire

Nasdaq · USD

ARDX

ARDELYX, INC.

Export transactions ↓
Tapewire entity
4972
SEC CIK
0001437402
Parsed reports
540

Last 12 months

Inside the activity.

1 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 202500
Jan 202601
Feb 2026125
Mar 202601
Apr 202601
May 2026020
Jun 202602
Jul 202601
Aug 2026021
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 26, 2024 Filed Dec 27, 2024 22:57 UTC
MOTT DAVID MDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.55 $0.00
Disclosure

SEC source: 0001628280-24-052533 · wk-form4_1735340223.xml · derivative · entry 2

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2032-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
December 26, 2024 Filed Dec 27, 2024 22:57 UTC
MOTT DAVID MDirector
Exercise / conversionCommon Stock 100,000 $0.55 $55,000.00
Disclosure

SEC source: 0001628280-24-052533 · wk-form4_1735340223.xml · nonDerivative · entry 1

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,738,765

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.

Read SEC document
December 19, 2024 Filed Dec 23, 2024 22:59 UTC
MOTT DAVID MDirector
PurchaseCommon Stock 213,300 $4.67 $996,580.26
Disclosure

SEC source: 0001628280-24-052363 · wk-form4_1734994751.xml · nonDerivative · entry 1

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,638,765

F1 · price: Transaction was executed in multiple trades in prices ranging from $4.55 to $4.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.

Read SEC document
December 10, 2024 Filed Dec 13, 2024 00:02 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001628280-24-051104 · wk-form4_1734048116.xml · derivative · entry 5

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 520,000

Underlying: Common Stock · 25,000 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
December 10, 2024 Filed Dec 13, 2024 00:02 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 25,000 $5.26 $131,620.00
Disclosure

SEC source: 0001628280-24-051104 · wk-form4_1734048116.xml · nonDerivative · entry 2

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,150,385

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

F2 · price: Transaction was executed in multiple trades in prices ranging from $5.22 to $5.33, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 10, 2024 Filed Dec 13, 2024 00:02 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionCommon Stock 25,000 $0.99 $24,750.00
Disclosure

SEC source: 0001628280-24-051104 · wk-form4_1734048116.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,175,385

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

Read SEC document
November 25, 2024 Filed Nov 28, 2024 01:15 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 25,000 $5.38 $134,482.50
Disclosure

SEC source: 0001628280-24-049423 · wk-form4_1732756544.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,150,385

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

F2 · price: Transaction was executed in multiple trades in prices ranging from $5.30 to $5.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:37 UTC
Williams Laura AChief Medical Officer
SaleCommon Stock 7,366 $4.79 $35,316.29
Disclosure

SEC source: 0001628280-24-049057 · wk-form4_1732318656.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,745

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,371 shares under the Ardelyx Employee Stock Purchase Plan in August 2024.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 18:22 UTC
Blanks RobertSee Remarks
SaleCommon Stock 4,941 $4.79 $23,689.62
Disclosure

SEC source: 0001628280-24-049047 · wk-form4_1732317736.xml · nonDerivative · entry 1

Blanks Robert · CIK 0001815433 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,421

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 18:33 UTC
Renz Justin AChief Financial Officer
SaleCommon Stock 5,260 $4.79 $25,219.07
Disclosure

SEC source: 0001628280-24-049053 · wk-form4_1732318388.xml · nonDerivative · entry 1

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,139

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,142 shares under the Ardelyx Employee Stock Purchase Plan in August 2024.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:34 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 2,243 $4.79 $10,754.06
Disclosure

SEC source: 0001628280-24-049055 · wk-form4_1732318487.xml · nonDerivative · entry 2

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 151,373

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:34 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 4,941 $4.79 $23,689.62
Disclosure

SEC source: 0001628280-24-049055 · wk-form4_1732318487.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 297,005

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:31 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 31,980 $4.79 $153,328.11
Disclosure

SEC source: 0001628280-24-049051 · wk-form4_1732318299.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,175,385

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:24 UTC SaleCommon Stock 7,046 $4.79 $33,782.05
Disclosure

SEC source: 0001628280-24-049049 · wk-form4_1732317858.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,334

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 13, 2024 Filed Nov 14, 2024 21:26 UTC
MOTT DAVID MDirector
PurchaseCommon Stock 215,868 $4.62 $996,597.80
Disclosure

SEC source: 0001628280-24-047919 · wk-form4_1731619603.xml · nonDerivative · entry 1

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,425,465

F1 · price: Transaction was executed in multiple trades in prices ranging from $4.435 to $4.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 22:00 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 2,743 $4.90 $13,440.70
Disclosure

SEC source: 0001628280-24-047271 · wk-form4_1731448844.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,207,365

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 23:00 UTC
Rosenbaum David P.Chief Development Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 27,171 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001628280-24-046753 · wk-form4_1731106849.xml · derivative · entry 5

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 0

Underlying: Common Stock · 27,171 shares

Expires 2029-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option became exercisable as it vested and the shares subject to the option vested in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F1 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 23:00 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 27,171 $6.10 $165,743.10
Disclosure

SEC source: 0001628280-24-046753 · wk-form4_1731106849.xml · nonDerivative · entry 2

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 153,616

F1 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 23:00 UTC
Rosenbaum David P.Chief Development Officer
Exercise / conversionCommon Stock 27,171 $2.32 $63,036.72
Disclosure

SEC source: 0001628280-24-046753 · wk-form4_1731106849.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 180,787

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
November 04, 2024 Filed Nov 6, 2024 22:59 UTC
Rosenbaum David P.Chief Development Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 27,172 $2.32 Strike: $2.32 $63,039.04
Disclosure

SEC source: 0001628280-24-045862 · wk-form4_1730933963.xml · derivative · entry 5

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 27,171

Underlying: Common Stock · 27,172 shares

Expires 2029-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option became exercisable as it vested and the shares subject to the option vested in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F1 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
November 04, 2024 Filed Nov 6, 2024 22:59 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 27,172 $5.95 $161,673.40
Disclosure

SEC source: 0001628280-24-045862 · wk-form4_1730933963.xml · nonDerivative · entry 2

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 153,616

F1 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
November 04, 2024 Filed Nov 6, 2024 22:59 UTC
Rosenbaum David P.Chief Development Officer
Exercise / conversionCommon Stock 27,172 $2.32 $63,039.04
Disclosure

SEC source: 0001628280-24-045862 · wk-form4_1730933963.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 180,788

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 12:24 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001628280-24-044440 · wk-form4_1730377456.xml · derivative · entry 5

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 545,000

Underlying: Common Stock · 25,000 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 12:24 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 25,000 $5.91 $147,740.00
Disclosure

SEC source: 0001628280-24-044440 · wk-form4_1730377456.xml · nonDerivative · entry 2

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,210,108

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

F2 · price: Transaction was executed in multiple trades in prices ranging from $5.80 to $5.951, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 12:24 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionCommon Stock 25,000 $0.99 $24,750.00
Disclosure

SEC source: 0001628280-24-044440 · wk-form4_1730377456.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,235,108

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

Read SEC document
October 11, 2024 Filed Oct 15, 2024 21:01 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 7,500 $6.01 $45,075.00
Disclosure

SEC source: 0001628280-24-042853 · wk-form4_1729026099.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,210,108

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

Read SEC document
September 27, 2024 Filed Oct 1, 2024 20:34 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 49,564 $6.92 $342,982.88
Disclosure

SEC source: 0001628280-24-041739 · wk-form4_1727814839.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 301,946

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 17, 2024.

Read SEC document
September 26, 2024 Filed Sep 27, 2024 20:09 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 3,000 $6.07 $18,210.00
Disclosure

SEC source: 0001628280-24-041474 · wk-form4_1727467780.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,217,608

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 22:14 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 5,312 $6.26 $33,253.65
Disclosure

SEC source: 0001628280-24-040556 · wk-form4_1726524865.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 153,616

F1 · price: Transaction was executed in multiple trades in prices ranging from $6.2601 to $6.265, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote

F2 · balance_after: Reflects the adjusted total which includes the purchase of 2,676 shares under the Ardelyx Employee Stock Purchase Plan in August 2024.

F3 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
September 11, 2024 Filed Sep 13, 2024 20:35 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001628280-24-040355 · wk-form4_1726259725.xml · derivative · entry 5

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 570,000

Underlying: Common Stock · 35,000 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
September 11, 2024 Filed Sep 13, 2024 20:35 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 35,000 $5.61 $196,399.00
Disclosure

SEC source: 0001628280-24-040355 · wk-form4_1726259725.xml · nonDerivative · entry 2

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,220,608

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

F3 · price: Transaction was executed in multiple trades in prices ranging from $5.551 to $5.651, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,099 shares under the Ardelyx Employee Stock Purchase Plan in August 2024.

Read SEC document
September 11, 2024 Filed Sep 13, 2024 20:35 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionCommon Stock 35,000 $0.99 $34,650.00
Disclosure

SEC source: 0001628280-24-040355 · wk-form4_1726259725.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,255,608

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,099 shares under the Ardelyx Employee Stock Purchase Plan in August 2024.

Read SEC document
August 27, 2024 Filed Aug 28, 2024 21:45 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 7,500 $6.22 $46,635.00
Disclosure

SEC source: 0001628280-24-038719 · wk-form4_1724881496.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,219,509

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

F2 · price: Transaction was executed in multiple trades in prices ranging from $6.161 to $6.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 20, 2024 Filed Aug 20, 2024 22:59 UTC
Rosenbaum David P.Chief Development Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 20,507 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001628280-24-037942 · wk-form4_1724194759.xml · derivative · entry 5

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Wife

Disclosed balance after: 49,806

Underlying: Common Stock · 20,507 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F3 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
August 20, 2024 Filed Aug 20, 2024 22:59 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 20,507 $6.00 $123,042.00
Disclosure

SEC source: 0001628280-24-037942 · wk-form4_1724194759.xml · nonDerivative · entry 3

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Wife

Disclosed balance after: 158,502

F3 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
August 20, 2024 Filed Aug 20, 2024 22:59 UTC
Rosenbaum David P.Chief Development Officer
Exercise / conversionCommon Stock 20,507 $0.99 $20,301.93
Disclosure

SEC source: 0001628280-24-037942 · wk-form4_1724194759.xml · nonDerivative · entry 2

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Wife

Disclosed balance after: 179,009

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 22:28 UTC
Williams Laura AChief Medical Officer
SaleCommon Stock 7,412 $5.86 $43,436.54
Disclosure

SEC source: 0001628280-24-038296 · wk-form4_1724365676.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,740

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 18:20 UTC
Blanks RobertSee Remarks
SaleCommon Stock 4,969 $5.86 $29,119.83
Disclosure

SEC source: 0001628280-24-038283 · wk-form4_1724365226.xml · nonDerivative · entry 1

Blanks Robert · CIK 0001815433 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,362

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 18:25 UTC
Renz Justin AChief Financial Officer
SaleCommon Stock 5,289 $5.86 $30,995.13
Disclosure

SEC source: 0001628280-24-038291 · wk-form4_1724365500.xml · nonDerivative · entry 1

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,257

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 22:26 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 2,250 $5.86 $13,185.68
Disclosure

SEC source: 0001628280-24-038293 · wk-form4_1724365582.xml · nonDerivative · entry 2

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wife

Disclosed balance after: 156,252

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · ownership.nature: The shares are directly held by the Reporting Person's wife.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 22:26 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 4,969 $5.86 $29,119.83
Disclosure

SEC source: 0001628280-24-038293 · wk-form4_1724365582.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,510

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 22:24 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 32,225 $5.86 $188,848.17
Disclosure

SEC source: 0001628280-24-038289 · wk-form4_1724365438.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,227,009

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 22:22 UTC SaleCommon Stock 7,089 $5.86 $41,543.67
Disclosure

SEC source: 0001628280-24-038287 · wk-form4_1724365356.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,380

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 22:21 UTC SaleCommon Stock 3,567 $5.86 $20,903.69
Disclosure

SEC source: 0001628280-24-038285 · wk-form4_1724365292.xml · nonDerivative · entry 1

Felsch Robert Ora · CIK 0001917819 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,560

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 16, 2024 Filed Aug 20, 2024 22:59 UTC
Rosenbaum David P.Chief Development Officer
SaleCommon Stock 20,000 $5.94 $118,740.00
Disclosure

SEC source: 0001628280-24-037942 · wk-form4_1724194759.xml · nonDerivative · entry 1

Rosenbaum David P. · CIK 0001611311 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 356,479

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 17, 2024.

F2 · price: Transaction was executed in multiple trades in prices ranging from $5.92 to $5.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 22:16 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 1,229 $5.71 $7,017.59
Disclosure

SEC source: 0001628280-24-037315 · wk-form4_1723673808.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,259,234

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

Read SEC document
August 08, 2024 Filed Aug 16, 2024 22:10 UTC
Foster Eric DuaneChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 230,000 $0.00 Strike: $5.87 $0.00
Disclosure

SEC source: 0001628280-24-037607 · wk-form4_1723846234.xml · derivative · entry 2

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,000

Underlying: Common Stock · 230,000 shares

Expires 2034-08-08

F2 · derivative.exercise_date: Twenty Five Percent (25%) of the shares subject to the option vest on August 8, 2025 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
August 08, 2024 Filed Aug 16, 2024 22:10 UTC
Foster Eric DuaneChief Commercial Officer
GrantCommon Stock 180,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-037607 · wk-form4_1723846234.xml · nonDerivative · entry 1

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,000

F1 · shares: Consists of 180,000 Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
July 29, 2024 Filed Jul 31, 2024 23:54 UTC
RAAB MICHAELDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001628280-24-033836 · wk-form4_1722470059.xml · derivative · entry 5

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 605,000

Underlying: Common Stock · 30,000 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
July 29, 2024 Filed Jul 31, 2024 23:54 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 30,000 $5.64 $169,314.00
Disclosure

SEC source: 0001628280-24-033836 · wk-form4_1722470059.xml · nonDerivative · entry 2

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,260,463

F1 · kind: Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.

F2 · price: Transaction was executed in multiple trades in prices ranging from $5.61 to $5.695, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.